Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 51

References for PMC Articles for PubMed (Select 21999779)

2.

Costing human rights and community support interventions as a part of universal access to HIV treatment and care in a Southern African setting.

Jones L, Akugizibwe P, Clayton M, Amon JJ, Sabin ML, Bennett R, Stegling C, Baggaley R, Kahn JG, Holmes CB, Garg N, Obermeyer CM, Mack CD, Williams P, Smyth C, Vitoria M, Crowley S, Williams B, McClure C, Granich R, Hirnschall G.

Curr HIV Res. 2011 Sep;9(6):416-28.

3.

Prevention of HIV-1 infection with early antiretroviral therapy.

Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Kumwenda J, Grinsztejn B, Pilotto JH, Godbole SV, Mehendale S, Chariyalertsak S, Santos BR, Mayer KH, Hoffman IF, Eshleman SH, Piwowar-Manning E, Wang L, Makhema J, Mills LA, de Bruyn G, Sanne I, Eron J, Gallant J, Havlir D, Swindells S, Ribaudo H, Elharrar V, Burns D, Taha TE, Nielsen-Saines K, Celentano D, Essex M, Fleming TR; HPTN 052 Study Team.

N Engl J Med. 2011 Aug 11;365(6):493-505. doi: 10.1056/NEJMoa1105243. Epub 2011 Jul 18.

4.

Evaluation of large-scale combination HIV prevention programs: essential issues.

Padian NS, McCoy SI, Manian S, Wilson D, Schwartländer B, Bertozzi SM.

J Acquir Immune Defic Syndr. 2011 Oct 1;58(2):e23-8. doi: 10.1097/QAI.0b013e318227af37.

PMID:
21694607
5.

Towards an improved investment approach for an effective response to HIV/AIDS.

Schwartländer B, Stover J, Hallett T, Atun R, Avila C, Gouws E, Bartos M, Ghys PD, Opuni M, Barr D, Alsallaq R, Bollinger L, de Freitas M, Garnett G, Holmes C, Legins K, Pillay Y, Stanciole AE, McClure C, Hirnschall G, Laga M, Padian N; Investment Framework Study Group.

Lancet. 2011 Jun 11;377(9782):2031-41. doi: 10.1016/S0140-6736(11)60702-2.

PMID:
21641026
6.

Acceptability of pre-exposure prophylaxis as an HIV prevention strategy: barriers and facilitators to pre-exposure prophylaxis uptake among at-risk Peruvian populations.

Galea JT, Kinsler JJ, Salazar X, Lee SJ, Giron M, Sayles JN, Cáceres C, Cunningham WE.

Int J STD AIDS. 2011 May;22(5):256-62. doi: 10.1258/ijsa.2009.009255.

7.

Estimating the impact of expanded access to antiretroviral therapy on maternal, paternal and double orphans in sub-Saharan Africa, 2009-2020.

Anema A, Au-Yeung CG, Joffres M, Kaida A, Vasarhelyi K, Kanters S, Montaner JS, Hogg RS.

AIDS Res Ther. 2011 Mar 7;8:13. doi: 10.1186/1742-6405-8-13.

8.

Opt-out HIV testing during antenatal care: experiences of pregnant women in rural Uganda.

Larsson EC, Thorson A, Pariyo G, Conrad P, Arinaitwe M, Kemigisa M, Eriksen J, Tomson G, Ekström AM.

Health Policy Plan. 2012 Jan;27(1):69-75. doi: 10.1093/heapol/czr009. Epub 2011 Feb 3.

9.

Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.

Kesho Bora Study Group, de Vincenzi I.

Lancet Infect Dis. 2011 Mar;11(3):171-80. doi: 10.1016/S1473-3099(10)70288-7. Epub 2011 Jan 13. Erratum in: Lancet Infect Dis. 2011 Mar;11(3):159. Read, Jennifer S [corrected to Read, Jennifer].

PMID:
21237718
10.

Analysis of overall level of evidence behind Infectious Diseases Society of America practice guidelines.

Lee DH, Vielemeyer O.

Arch Intern Med. 2011 Jan 10;171(1):18-22. doi: 10.1001/archinternmed.2010.482.

PMID:
21220656
11.

A CD4+ cell count <200 cells per cubic millimeter at 2 years after initiation of combination antiretroviral therapy is associated with increased mortality in HIV-infected individuals with viral suppression.

Loutfy MR, Genebat M, Moore D, Raboud J, Chan K, Antoniou T, Milan D, Shen A, Klein MB, Cooper C, Machouf N, Rourke SB, Rachlis A, Tsoukas C, Montaner JS, Walmsley SL, Smieja M, Bayoumi A, Mills E, Hogg RS; CANOC Collaboration.

J Acquir Immune Defic Syndr. 2010 Dec;55(4):451-9.

PMID:
21105259
12.

An offer you can't refuse? Provider-initiated HIV testing in antenatal clinics in rural Malawi.

Angotti N, Dionne KY, Gaydosh L.

Health Policy Plan. 2011 Jul;26(4):307-15. doi: 10.1093/heapol/czq066. Epub 2010 Nov 2.

13.

Combination HIV prevention: significance, challenges, and opportunities.

Kurth AE, Celum C, Baeten JM, Vermund SH, Wasserheit JN.

Curr HIV/AIDS Rep. 2011 Mar;8(1):62-72. doi: 10.1007/s11904-010-0063-3. Review.

14.

Rapid implementation of an integrated large-scale HIV counseling and testing, malaria, and diarrhea prevention campaign in rural Kenya.

Lugada E, Millar D, Haskew J, Grabowsky M, Garg N, Vestergaard M, Kahn JG, Muraguri N, Mermin J.

PLoS One. 2010 Aug 26;5(8):e12435. doi: 10.1371/journal.pone.0012435. Erratum in: PLoS One. 2011;6(6). doi:10.1371/annotation/b3e1590a-5814-4848-958e-2af40d318936. Khan, James G [corrected to Kahn, James G]. PLoS One. 2010;5(9). doi: 10.1371/annotation/cd255375-7cf9-4b56-a81f-ec57e360c472. Kahn, James [corrected to Khan, James G].

16.

Ongoing drug use and outcomes from highly active antiretroviral therapy among injection drug users in a Canadian setting.

Krüsi A, Milloy MJ, Kerr T, Zhang R, Guillemi S, Hogg R, Montaner J, Wood E.

Antivir Ther. 2010;15(5):789-96. doi: 10.3851/IMP1614.

PMID:
20710061
17.

Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study.

Montaner JS, Lima VD, Barrios R, Yip B, Wood E, Kerr T, Shannon K, Harrigan PR, Hogg RS, Daly P, Kendall P.

Lancet. 2010 Aug 14;376(9740):532-9. doi: 10.1016/S0140-6736(10)60936-1. Epub 2010 Jul 16.

18.

Expanding access to HAART: a cost-effective approach for treating and preventing HIV.

Johnston KM, Levy AR, Lima VD, Hogg RS, Tyndall MW, Gustafson P, Briggs A, Montaner JS.

AIDS. 2010 Jul 31;24(12):1929-35. doi: 10.1097/QAD.0b013e32833af85d.

PMID:
20588171
19.

Antiretroviral regimens in pregnancy and breast-feeding in Botswana.

Shapiro RL, Hughes MD, Ogwu A, Kitch D, Lockman S, Moffat C, Makhema J, Moyo S, Thior I, McIntosh K, van Widenfelt E, Leidner J, Powis K, Asmelash A, Tumbare E, Zwerski S, Sharma U, Handelsman E, Mburu K, Jayeoba O, Moko E, Souda S, Lubega E, Akhtar M, Wester C, Tuomola R, Snowden W, Martinez-Tristani M, Mazhani L, Essex M.

N Engl J Med. 2010 Jun 17;362(24):2282-94. doi: 10.1056/NEJMoa0907736.

20.

Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco.

Das M, Chu PL, Santos GM, Scheer S, Vittinghoff E, McFarland W, Colfax GN.

PLoS One. 2010 Jun 10;5(6):e11068. doi: 10.1371/journal.pone.0011068.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk